Posaconazole Tablet, Delayed Release
Product Images NDC 43598-470

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 43598-470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Container (Container)
Posaconazole 100 mg delayed-release tablets label for oral use from Dr. Reddy's Laboratories Inc. The label states the product contains 60 film-coated tablets, each with 100 mg of posaconazole. It includes storage instructions, distributor information, a barcode, and a depiction of an oval tablet imprinted with '470.'*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of posaconazole, showing its molecular framework with fluorinated and triazole-containing rings, consistent with the active ingredient posaconazole in tablet form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.